U.S.A. develops and treats the new medicine _'s treatment of third liver

U.S.A. develops and treats the new medicine _'s treatment of third liver
The newest clinical trial of American researchers shows, a kind of new interferon has more prominent results on treating third liver.

According to " medical magazine of New England ", such new interferon to " wear, add the west " ( P egasy) . Researchers are between three years of 1999 and 1997, to distribute in Australia, Britain, Canada 9 third liver patient of countries and regions trying out such new interferon. Participate in 531 patient that test accept new interferon treat while being some, other one part accepts the regular treatment. Find through comparing with the test, the patient who accepts new treatment, there is condition of 39 that takes a favorable turn; And in the patient to accept routine treatment, the intersection of patient and third liver virus of 19 basically control only.

In addition the clinical trial finds, the new interferon side effect is relatively small, usually the patient only presents influenza symptom, and curative effect duration is lengthened, routine treatment needs to inject interferon three times every week, adopting new interferon only needs to inject once every week.
|